SynthesisBMC neurology2025

Comparative efficacy and safety of ocrelizumab in relapsing-remitting and primary progressive multiple sclerosis: A systematic review and meta-analysis.

Adil Nawaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.